Related Experiment Video

Updated: Aug 30, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Tumor chemopreventive activity of 3-O-acylated (--)-epigallocatechins

Ayako Kumagai1, Yasuo Nagaoka, Tomoko Obayashi

  • 1Department of Biotechnology, Faculty of Engineering, Kansai University, Suita, Osaka 564-8680, Japan.

Bioorganic & Medicinal Chemistry
|November 8, 2003
PubMed

Insights

New epigallocatechin derivatives show enhanced anti-tumor promotion. These compounds more effectively inhibited papilloma formation in mice compared to existing agents, suggesting potential for cancer chemoprevention.

Area of Science:

  • Medicinal Chemistry
  • Cancer Research
  • Pharmacology

Background:

  • Epigallocatechin gallate (EGCG) is a known anti-tumor promoter.
  • Developing novel chemopreventive agents is crucial for cancer control.
  • Epstein-Barr virus (EBV) early antigen activation is a target in carcinogenesis research.

Purpose of the Study:

  • To evaluate the anti-tumor promoting activities of novel epigallocatechin derivatives.
  • To compare the efficacy of these derivatives against established anti-tumor promoters.
  • To identify promising candidates for cancer chemoprevention.

Main Methods:

  • Synthesis of 3-O-octanoyl and 3-O-(2-methyloctanoyl)-epigallocatechins.
  • Assessment of anti-tumor promoting activity using a two-stage mouse skin carcinogenesis assay.
  • Measurement of inhibition of Epstein-Barr virus early antigen activation.

Main Results:

  • The synthesized epigallocatechin derivatives demonstrated significant anti-tumor promoting activity.
  • These derivatives inhibited papilloma formation 1.3-1.6 fold more effectively than EGCG.
  • Marked inhibition of Epstein-Barr virus early antigen activation was observed.

Conclusions:

  • 3-O-octanoyl and 3-O-(2-methyloctanoyl)-epigallocatechins are potent anti-tumor promoters.
  • These novel derivatives represent promising candidates for cancer chemoprevention strategies.
  • Further research into these compounds could lead to new therapeutic agents.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...